NDC 00132-0195-12: Pedia-Lax Glycerin 2.8 g/4mL Liquid
This is a package of Pedia-Lax Glycerin 2.8 g/4mL Liquid from C.B. Fleet Company, Inc., first listed with the FDA Feb 2019 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 0132-0195-12 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 0132 labeler · 0195 product · 12 package
- Package marketed since
- Feb 1, 2019
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 0132019512 5
- FDA record last changed
- Oct 15, 2026
Other active recalls for Glycerin (different manufacturers) — 5 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 895966
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Non-Standardized Chemical Allergen class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Pedia-Lax Glycerin 2.8 g/4mL is a rectal liquid product containing glycerin as its active ingredient. Glycerin is commonly used in rectal preparations to function as an osmotic agent and lubricant. This product is marketed as an over-the-counter drug under FDA's monograph rules for its category, rather than as an individually reviewed new drug application.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Glycerin — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00132-0195-12 You're viewing this Main listing | 6 APPLICATOR in 1 CARTON / 4 mL in 1 APPLICATOR | 2019-02-01 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Pedia-Lax 2.8 g/2.7mL 00132-0190-12 | C.B. | 4 liquids | $0.208 | — | Availability likely | — |
| Pedia-Lax 2.8 g/4mLthis 00132-0195-12 | C.B. | 6 applicators | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 7FLD91C86K
Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
2 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from C.B. Fleet Company, Inc. labeler code 00132
- Fleet Glycerin 2 g Suppository NDC 0132-0075-00
- Fleet sodium phosphate, dibasic and sodium phosphate, monobasic 7 g/230mL; 19 g/230mL Enema NDC 0132-0078-01
- Pedia-Lax Docusate Sodium 50 mg/15mL Liquid NDC 0132-0113-24
- Fleet glycerin 5.4 g Liquid NDC 0132-0185-01
- Pedia-Lax Glycerin 2.8 g/2.7mL Liquid NDC 0132-0190-12
- Fleet sodium phosphate, dibasic and sodium phosphate, monobasic 7 g/118mL; 19 g/118mL Enema NDC 0132-0201-10
- Pedia-Lax sodium phosphate, dibasic and sodium phosphate, monobasic 3.5 g/66mL; 9.5 g/66mL Enema NDC 0132-0202-20
- PHAZYME Simethicone 180 mg Capsule, Gelatin Coated NDC 0132-0208-12
- PHAZYME Simethicone 250 mg Capsule, Gelatin Coated NDC 0132-0211-12
- Phazyme Ultimate SIMETHICONE 500 mg Capsule, Liquid Filled NDC 0132-0222-20
- FLEET Mineral Oil 100 g/100mL Enema NDC 0132-0301-40
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses for relief of occasional constipation this product generally produces bowel movement in 1/4 to 1 hour
⏱️ Dosage and Administration ▾
Directions Single Daily Dosage (per 24 hours) children 2 to under 6 years : one suppository per day or as directed by a doctor children under 2 years : consult a doctor Administering the laxative: CAUTION: REMOVE ORANGE PROTECTIVE SHIELD BEFORE INSERTING. Hold unit upright, grasping bulb of unit with fingers. Grasp orange protective shield with other hand, pull gently to remove.
With steady pressure, gently insert tip into rectum with a slight side-to-side movement, with tip pointing toward navel. Discontinue use if resistance is encountered. Forcing the tip can result in injury.
Insertion may be easier if child receiving suppository bears down as if having a bowel movement. This helps relax the muscles around the anus. Squeeze the bulb until nearly all liquid is expelled.
While continuing to squeeze the bulb, remove tip from rectum and discard unit. It is not necessary to empty unit completely. The unit contains more than the amount of liquid needed for effective use.
A small amount of liquid will remain in the unit after squeezing. Left-side position: Place child on left side with knees bent and arms resting comfortably. Knee-chest position: Have child kneel, then lower head and chest forward until left side of face is resting on surface with left arm folded comfortably.
⚠️ Warnings ▾
Warnings For rectal use only May cause rectal discomfort or a burning sensation. Ask a doctor before using any laxative if the child has abdominal pain, nausea or vomiting a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week if constipation continues after one week of use, contact your child's doctor Stop using this product and consult a doctor if the child has rectal bleeding no bowel movement within 1 hour of using this product These symptoms may indicate a serious condition.
Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
🧪 Active Ingredient ▾
Active ingredient (in each 2.7 mL average delivered dose) Glycerin 2.8 g
🧪 Inactive Ingredients ▾
Inactive ingredients edetate disodium, purified water
🎯 Purpose ▾
Purpose Hyperosmotic laxative
📄 Ask a Doctor Before Use If ▾
Ask a doctor before using any laxative if the child has abdominal pain, nausea or vomiting a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week if constipation continues after one week of use, contact your child's doctor
📄 Stop Use and Ask a Doctor If ▾
Stop using this product and consult a doctor if the child has rectal bleeding no bowel movement within 1 hour of using this product These symptoms may indicate a serious condition.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
📄 Other Information ▾
Other information carton sealed for safety. If seal with Fleet emblem on bottom flap or top flap is broken or missing, do not use.
📄 Questions or Comments ▾
Questions? 1-866-255-6960 or www.pedia-lax.com
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL Baby Care Pedia -Lax ® Liquid glycerin suppositories rectal laxative 6 applicators (4 ml each) PRINCIPAL DISPLAY PANEL Baby Care Pedia-Lax ® Liquid glycerin suppositories rectal laxative 6 applicators (4 ml each)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |